These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 12115575

  • 1. Supra-additive effect with concurrent paclitaxel and cisplatin in vulvar squamous cell carcinoma in vitro.
    Raitanen M, Rantanen V, Kulmala J, Helenius H, Grénman R, Grénman S.
    Int J Cancer; 2002 Jul 10; 100(2):238-43. PubMed ID: 12115575
    [Abstract] [Full Text] [Related]

  • 2. In vitro concurrent paclitaxel and radiation of four vulvar squamous cell carcinoma cell lines.
    Jaakkola M, Rantanen V, Grénman S, Kulmala J, Grénman R.
    Cancer; 1996 May 01; 77(9):1940-6. PubMed ID: 8646696
    [Abstract] [Full Text] [Related]

  • 3. Additive and supra-additive cytotoxicity of cisplatin-taxane combinations in ovarian carcinoma cell lines.
    Engblom P, Rantanen V, Kulmala J, Helenius H, Grènman S.
    Br J Cancer; 1999 Jan 01; 79(2):286-92. PubMed ID: 9888470
    [Abstract] [Full Text] [Related]

  • 4. Paclitaxel combined with fractionated radiation in vitro: a study with vulvar squamous cell carcinoma cell lines.
    Raitanen M, Rantanen V, Kulmala J, Pulkkinen J, Klemi P, Grénman S, Grénman R.
    Int J Cancer; 2002 Feb 20; 97(6):853-7. PubMed ID: 11857367
    [Abstract] [Full Text] [Related]

  • 5. Concurrent use of vinorelbine and gefitinib induces supra-additive effect in head and neck squamous cell carcinoma cell lines.
    Erjala K, Raitanen M, Kulmala J, Grénman R.
    J Cancer Res Clin Oncol; 2007 Mar 20; 133(3):169-76. PubMed ID: 17021904
    [Abstract] [Full Text] [Related]

  • 6. Radiation response of vulvar squamous cell carcinoma (UM-SCV-1A, UM-SCV-1B, UM-SCV-2, and A-431) cells in vitro.
    Pekkola-Heino K, Kulmala J, Grenman S, Carey TE, Grenman R.
    Cancer Res; 1989 Sep 01; 49(17):4876-8. PubMed ID: 2758419
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Vulvar squamous cell carcinoma cell lines are sensitive to paclitaxel in vitro.
    Jaakkola M, Rantanen V, Grénman S, Kulmala J, Grénman R.
    Anticancer Res; 1997 Sep 01; 17(2A):939-43. PubMed ID: 9137431
    [Abstract] [Full Text] [Related]

  • 9. Concurrent cetuximab, cisplatin, and radiation for squamous cell carcinoma of the head and neck in vitro.
    Zhang N, Erjala K, Kulmala J, Qiu X, Sundvall M, Elenius K, Grénman R.
    Radiother Oncol; 2009 Sep 01; 92(3):388-92. PubMed ID: 19447510
    [Abstract] [Full Text] [Related]

  • 10. In vitro schedule-dependent interaction between paclitaxel and cisplatin in human carcinoma cell lines.
    Kano Y, Akutsu M, Tsunoda S, Suzuki K, Yazawa Y.
    Cancer Chemother Pharmacol; 1996 Sep 01; 37(6):525-30. PubMed ID: 8612305
    [Abstract] [Full Text] [Related]

  • 11. Anti-neoplastic activity of topotecan versus cisplatin, etoposide and paclitaxel in four squamous cell cancer cell lines of the female genital tract using an ATP-Tumor Chemosensitivity Assay.
    Boabang P, Kurbacher CM, Kohlhagen H, Waida A, Amo-Takyi BK.
    Anticancer Drugs; 2000 Nov 01; 11(10):843-8. PubMed ID: 11142692
    [Abstract] [Full Text] [Related]

  • 12. Phenotypic characterization, karyotype analysis and in vitro tamoxifen sensitivity of new ER-negative vulvar carcinoma cell lines, UM-SCV-1A and UM-SCV-1B.
    Grénman SE, Van Dyke DL, Worsham MJ, England B, McClatchey KD, Hopkins M, Babu VR, Grénman R, Carey TE.
    Int J Cancer; 1990 May 15; 45(5):920-7. PubMed ID: 2335395
    [Abstract] [Full Text] [Related]

  • 13. Regulation of proliferation of UM-SCV-1A and UM-SCV-6 vulvar carcinoma cells by cytokines.
    Vihko KK, Seppänen M, Henttinen T, Punnonen J, Grénman S, Punnonen R.
    Cancer Immunol Immunother; 1997 Jan 15; 43(6):368-74. PubMed ID: 9067409
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antagonism between gefitinib and cisplatin in non-small cell lung cancer cells: why randomized trials failed?
    Tsai CM, Chen JT, Stewart DJ, Chiu CH, Lai CL, Hsiao SY, Chen YM, Chang KT.
    J Thorac Oncol; 2011 Mar 15; 6(3):559-68. PubMed ID: 21258258
    [Abstract] [Full Text] [Related]

  • 16. Activity of fenretinide plus chemotherapeutic agents in small-cell lung cancer cell lines.
    Kalemkerian GP, Ou X.
    Cancer Chemother Pharmacol; 1999 Mar 15; 43(2):145-50. PubMed ID: 9923820
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The platinum compounds and paclitaxel in the management of carcinomas of the endometrium and uterine cervix.
    Thigpen T, Vance RB, Khansur T.
    Semin Oncol; 1995 Oct 15; 22(5 Suppl 12):67-75. PubMed ID: 7481864
    [Abstract] [Full Text] [Related]

  • 19. Concomitant chemoirradiation with vinorelbine and gefitinib induces additive effect in head and neck squamous cell carcinoma cell lines in vitro.
    Erjala K, Zhang N, Sundvall M, Kulmala J, Elenius K, Grénman R.
    Radiother Oncol; 2007 Oct 15; 85(1):138-45. PubMed ID: 17923163
    [Abstract] [Full Text] [Related]

  • 20. Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results.
    Belli L, LeChevalier T, Gottfried M, Adams D, Ruffie P, LeCesne A, Tete L, Pellae-Cosset B.
    Semin Oncol; 1995 Dec 15; 22(6 Suppl 15):29-33. PubMed ID: 8643967
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.